News Autoimmunity

CE marked QUANTA Flash Circulating Calprotectin now available!

May 10, 2021 - UK

CCPSm2

CE marked QUANTA Flash Circulating Calprotectin now available!

Circulating Calprotectin has been identified as a marker which can aid in the stratification of Covid-19 patients in a hospital setting, offering clinicians valuable information on the likelihood of more severe disease progression in patients. Werfen are excited to be able to offer the CE marked QUANTA Flash assay for circulating calprotectin, available for use on the BIO-FLASH and AcuStar random access chemiluminescence systems.

 

Contact Werfen UK for more information.  Email: sales@werfen.com

Share Press Release:

LinkedIn twitter facebook
Contact Us

Contact us directly using the below, or by filling out the form.

Tel: 01925 810 141 - Option 6

 

Tel: 0800 102 6342

 

Tel: 01925 810 141 - Option 1

DATA PROCESSING NOTICE:

Werfen Ltd will process your personal data to respond to your requests for information or support, or to understand your needs and provide you with a better service relying on our legitimate interest to do so. You can find more information about our data privacy practices and how to exercise your rights in our Privacy Policy. You can also contact us at DPO-uk@werfen.com.